Asia300

IHH Healthcare Bhd.

Malaysia

  • 1m
  • 3m
  • 6m
  • 1y
  • 2y
  • 5y
Apr 28, 2017
Prev close: 6.18
Apr 28, 2017
Market cap:
Market cap(USD):
50,872.1M
11,719M
Shares: 8,231.73M

Currency in MYR

Company profile

Market(Ticker): KLS(5225)
Sector:
Industry:
Health Services
Hospital/Nursing Management
Full time employees: 30,000

Business summary

IHH Healthcare Bhd. is an investment holding company, engages in the provision of healthcare services. It operates through the following segments: Parkway Pantai, Acibadem, IMU Health, and Parkway Life REIT. The Parkway Pantai segment is a hospital operator and healthcare service provider in Asia. The Acibadem segment operates as a hospital and healthcare service provider in Central Eastern Europe, Middle East, and North Africa. The IMU segment is an education service provider in Malaysia. The Parkway Life REIT offers real estate investment trust. The company was founded on May 21, 2010 and is headquartered in Kuala Lumpur, Malaysia.

Company background

IHH Healthcare runs 37 private hospitals in 10 countries, including China and India. Its facilities have a total of more than 6,000 beds.

Headquartered in Malaysia, the company also sees Singapore and Turkey as its home markets. Its hospitals in these three countries attract affluent patients from across Southeast Asia and the Middle East. The group's Mount Elizabeth and Gleneagles hospitals in Singapore are considered particularly prestigious, thanks to their state-of-the-art medical equipment.

IHH is 44% owned by Khazanah Nasional, an investment arm of the Malaysian government. Khazanah in 2010 defeated a rival bid from India's Fortis Healthcare to take control of Parkway Holdings, a then-listed Singaporean company, which owned hospitals in Malaysia and Singapore. Today, Parkway is a wholly owned IHH subsidiary.

IHH is listed in both Malaysia and Singapore. The group is led by CEO Tan See Leng, who is also a doctor. Tan joined Parkway in 2004 and held various high-ranking positions before the company slid under IHH's umbrella.

Globally, IHH is the second-largest health care operator by market capitalization. Japanese trading house Mitsui & Co. is a major shareholder.

In the news

Financial highlights

Dec 2016

  • Local currency
  • US Dollar
Revenue 10,021.88M
Gross profit 2,657.16M
Operating income 1,261.03M
Income before tax 860.94M
Net income 612.35M
EBITDA 2,060.91M
Diluted EPS 0.07
Dividends per share 0.03
Total assets 37,187.95M
Total liabilities 13,294.79M
Total equity 21,985.74M
Operating cash flow 1,730.45M

Currency in MYR

Revenue 2,419.15M
Gross profit 641.40M
Operating income 304.39M
Income before tax 207.82M
Net income 147.81M
EBITDA 497.47M
Diluted EPS 0.01
Dividends per share 0.00
Total assets 8,289.78M
Total liabilities 2,963.61M
Total equity 4,900.96M
Operating cash flow 417.70M

Currency in USD

Valuation measures

Dec 2016

PER 85.34
ROA 1.68%
ROE 2.77%
Operating margin 12.58%
Profit margin 6.11%

Key executive

  • CEO & Non-Independent Executive Director: See Leng Tan
  • Chief Financial Officer: Soon Teck Low
  • Group Head-Internal Audit: Audrey Huang
  • Assistant Vice President-Investor Relations: Penelope Koh
  • Group Head-Human Capital Management: Juan Jim Tan

Share holders

  • Khazanah Nasional Bhd. (Investment Company)(41.1%)
  • Mitsui & Co., Ltd.(18.0%)
  • Employees Provident Fund(9.9%)
  • Singapore Exchange Ltd.(5.2%)
  • AYDINLAR MEHMET ALI(2.1%)
  • Public Mutual Bhd.(1.8%)
  • GIC Pte Ltd. (Investment Management)(1.8%)
  • Kuwait Investment Authority (Investment Management)(1.4%)
  • BlackRock Fund Advisors(1.1%)
  • The Vanguard Group, Inc.(1.1%)

Address

  • Website: http://www.ihh-healthcare.com
  • Address: Pantai Hospital Kuala Lumpur, Level 11 Block A, Taman Bukit Pantai, Kuala Lumpur, 59100, Malaysia
  • Phone: +60.3.2298.9898

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.